UCrest Bhd (XKLS:0005) Change In Receivables: RM2.44 Mil (TTM As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is UCrest Bhd Change In Receivables?

UCrest Bhd XKLS:0005 Change In Receivables is RM2.44 Mil as of May. 2026. The stock has 4 warning signs investors should review.

UCrest Bhd's change in receivables for the quarter that ended in May. 2026 was RM-1.87 Mil. It means UCrest Bhd's Accounts Receivable increased by RM1.87 Mil from Feb. 2026 to May. 2026 .

UCrest Bhd's change in receivables for the fiscal year that ended in May. 2026 was RM2.44 Mil. It means UCrest Bhd's Accounts Receivable declined by RM2.44 Mil from May. 2025 to May. 2026 .

UCrest Bhd's Accounts Receivable for the quarter that ended in May. 2026 was RM22.92 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. UCrest Bhd's Days Sales Outstanding for the three months ended in May. 2026 was 490.38.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. UCrest Bhd's liquidation value for the three months ended in May. 2026 was RM20.81 Mil.

UCrest Bhd  (XKLS:0005) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

UCrest Bhd's Days Sales Outstanding for the quarter that ended in May. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=22.915/4.264*91
=490.38

2. In Ben Graham's calculation of liquidation value, UCrest Bhd's accounts receivable are only considered to be worth 75% of book value:

UCrest Bhd's liquidation value for the quarter that ended in May. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=9.31-5.703+0.75 * 22.915+0.5 * 0.043
=20.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UCrest Bhd Change In Receivables Related Terms

UCrest Bhd Change In Receivables Historical Data

* Premium members only.

The historical data trend for UCrest Bhd's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UCrest Bhd Change In Receivables Chart

UCrest Bhd Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.11 -10.68 -0.11 6.92 2.44

UCrest Bhd Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.17 -0.01 4.04 0.28 -1.87

UCrest Bhd Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM2.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of RM2.44 Mil mean?
UCrest Bhd (XKLS:0005) has a Change In Receivables of RM2.44 Mil as of May. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for UCrest Bhd and its competitors.
Is UCrest Bhd's Change In Receivables too high?
UCrest Bhd's current Change In Receivables is RM2.44 Mil.
How does UCrest Bhd's Change In Receivables compare to VEEV and BTSG?
UCrest Bhd's Change In Receivables of RM2.44 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Healthcare Providers & Services company?
A good Change In Receivables depends on the Healthcare Providers & Services industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for UCrest Bhd and its competitors. UCrest Bhd's current Change In Receivables is RM2.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UCrest Bhd stock overvalued right now?
Based on GuruFocus' analysis, UCrest Bhd (XKLS:0005) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.08, compared to a current price of RM0.07 — trading 18.8% below its estimated fair value. The current Change In Receivables is RM2.44 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For UCrest Bhd (XKLS:0005), the current Change In Receivables is RM2.44 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

UCrest Bhd Business Description

Address 8, First Avenue, Bandar Utama, 6th Floor, Unit 4, Petaling Jaya, SGR, MYS, 47800
UCrest Bhd is a technology provider company that engages in network design, product development, and software development. The firm provider of Cloud Hospital and mobile health services. The company offers an i-Medic platform for diagnosis, management, and treatment of chronic diseases such as cardiovascular diseases (CVD), cancer, diabetes, hypertension, sleep apnea, stroke rehabilitation, and other diseases.